Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 691 AL 705

Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical Trial

Sevigny J, Suhy J, Chiao P, Chen T, Klein G, Purcell D, Oh J, Verma A, Sampat M, Barakos J.

Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):1-7. doi: 10.1097/WAD.0000000000000144.

Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up

Turró-Garriga O, Garre-Olmo J, Calvó-Perxas L, Reñé-Ramírez R, Gascón-Bayarri J, Conde-Sala JL.

J Alzheimers Dis. 2016;51(2):357-66. doi: 10.3233/JAD-150706.

Frontal Lobe Degeneration in Adults with Down Syndrome and Alzheimer's Disease: A Review

Fonseca LM, Yokomizo JE, Bottino CM, Fuentes D.

Dement Geriatr Cogn Disord. 2016;41(3-4):123-36. doi: 10.1159/000442941. Epub 2016 Feb 19.

Interleukin-18 -137 G/C and -607 C/A polymorphisms and Alzheimer's disease risk: a meta-analysis

Zhang J, Song T, Liang H, Lian J, Zhang G, Gong H.

Neurol Sci. 2016 Jun;37(6):921-7. doi: 10.1007/s10072-016-2516-y. Epub 2016 Feb 20.

On cognitive ecology and the environmental factors that promote Alzheimer disease: lessons from Octodon degus (Rodentia: Octodontidae)

Rivera DS, Inestrosa NC, Bozinovic F.

Biol Res. 2016 Feb 20;49:10. doi: 10.1186/s40659-016-0074-7.

Vascular and Metabolic Factors in Alzheimer's Disease and Related Dementias: Introduction

Iadecola C.

Cell Mol Neurobiol. 2016 Mar;36(2):151-4. doi: 10.1007/s10571-015-0319-y. Epub 2016 Feb 22.

Could Better Phenotyping Small Vessel Disease Provide New Insights into Alzheimer Disease and Improve Clinical Trial Outcomes?

Marnane M, Hsiung GY.

Curr Alzheimer Res. 2016;13(7):750-63. doi: 10.2174/1567205013666160222112634.

Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease: Is Inflammatory Signaling a Key Player?

Djordjevic J, Sabbir MG, Albensi BC.

Curr Alzheimer Res. 2016;13(7):730-8. doi: 10.2174/1567205013666160222110320.

Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease

Hernandez L, Ozen A, DosSantos R, Getsios D.

Pharmacoeconomics. 2016 Jul;34(7):681-707. doi: 10.1007/s40273-016-0392-1.

Retrogenesis of semantic knowledge: Comparative approach of acquisition and deterioration of concepts in semantic memory

Simoes Loureiro I, Lefebvre L.

Neuropsychology. 2016 Oct;30(7):853-9. doi: 10.1037/neu0000272. Epub 2016 Feb 25.

Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment

Suppa P, Hampel H, Kepp T, Lange C, Spies L, Fiebach JB, Dubois B, Buchert R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2016;51(3):867-73. doi: 10.3233/JAD-150804.

Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms

Anderson-Mooney AJ, Schmitt FA, Head E, Lott IT, Heilman KM.

Brain Cogn. 2016 Apr;104:48-57. doi: 10.1016/j.bandc.2016.02.007. Epub 2016 Feb 27.

Imbalanced cholesterol metabolism in Alzheimer's disease

Xue-Shan Z, Juan P, Qi W, Zhong R, Li-Hong P, Zhi-Han T, Zhi-Sheng J, Gui-Xue W, Lu-Shan L.

Clin Chim Acta. 2016 May 1;456:107-114. doi: 10.1016/j.cca.2016.02.024. Epub 2016 Mar 2.

The Effects of Cognitive Training for Elderly: Results from My Mind Project

Giuli C, Papa R, Lattanzio F, Postacchini D.

Rejuvenation Res. 2016 Dec;19(6):485-494. doi: 10.1089/rej.2015.1791. Epub 2016 Apr 8.

Optimal nonpharmacological management of agitation in Alzheimer's disease: challenges and solutions

Millán-Calenti JC, Lorenzo-López L, Alonso-Búa B, de Labra C, González-Abraldes I, Maseda A.

Clin Interv Aging. 2016 Feb 22;11:175-84. doi: 10.2147/CIA.S69484. eCollection 2016.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias